{
  "data_type": "CVE",
  "data_format": "MITRE",
  "data_version": "4.0",
  "CVE_data_meta": {
    "ID": "CVE-2015-3956",
    "ASSIGNER": "ics-cert@hq.dhs.gov"
  },
  "problemtype": {
    "problemtype_data": [
      {
        "description": [
          {
            "lang": "en",
            "value": "CWE-345"
          }
        ]
      }
    ]
  },
  "references": {
    "reference_data": [
      {
        "url": "https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01",
        "name": "https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01",
        "refsource": "MISC",
        "tags": [
          "Mitigation",
          "US Government Resource",
          "Third Party Advisory"
        ]
      }
    ]
  },
  "description": {
    "description_data": [
      {
        "lang": "en",
        "value": "Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes from unauthenticated devices on the host network. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue."
      }
    ]
  }
}